MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 - Germany

This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

: Medikation Imatinib (ATC Versionsübergang)

Raw xml | Download


<MedicationStatement xmlns="http://hl7.org/fhir">
  <id value="mii-exa-onko-medikation-imatinib-atc-version-transition"/>
  <meta>
    <profile
             value="https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-systemische-therapie-medikation|2027.0.0-ballot.1"/>
  </meta>
  <language value="de"/>
  <text>
    <status value="generated"/>
    <div xml:lang="de" lang="de"><hr/><p><b>German</b></p><hr/><p class="res-header-id"><b>Generated Narrative: MedicationStatement mii-exa-onko-medikation-imatinib-atc-version-transition</b></p><a name="de-mii-exa-onko-medikation-imatinib-atc-version-transition"> </a><a name="de-hcmii-exa-onko-medikation-imatinib-atc-version-transition"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-mii-pr-onko-systemische-therapie-medikation.html">MII PR Onkologie Systemische Therapie Medikation</a> version: 2027.0.0-ballot.1</p></div><p><b>basedOn</b>: <a href="CarePlan-mii-exa-onko-tumorkonferenz-01.html">CarePlan: identifier = Tumorkonferenz_1; status = active; intent = plan; category = postoperative Tumorkonferenz (Planung der postoperativen Therapie, z. B. zur Frage adjuvante Therapie); created = 2024-01-11</a></p><p><b>partOf</b>: <a href="Procedure-mii-exa-onko-systemische-therapie-1.html">Procedure Chemotherapie</a></p><p><b>status</b>: Completed</p><p><b>medication</b>: <span title="Codes:{http://fhir.de/CodeSystem/bfarm/atc L01XE01}, {http://fhir.de/CodeSystem/bfarm/atc L01EA01}">Imatinib (BCR-ABL Tyrosinkinase-Inhibitor)</span></p><p><b>subject</b>: <a href="Patient-example.html">Erika Beispiel  Female, DoB: 1965-04-12</a></p><p><b>effective</b>: 2020-12-01 --&gt; 2024-08-30</p><p><b>note</b>: </p><blockquote><div><p>CML-Protokoll mit Imatinib</p>
</div></blockquote></div>
  </text>
  <basedOn>🔗 
    <reference value="CarePlan/mii-exa-onko-tumorkonferenz-01"/>
  </basedOn>
  <partOf>🔗 
    <reference value="Procedure/mii-exa-onko-systemische-therapie-1"/>
  </partOf>
  <status value="completed"/>
  <medicationCodeableConcept>
    <coding>
      <system value="http://fhir.de/CodeSystem/bfarm/atc"/>
      <version value="2020"/>
      <code value="L01XE01"/>
      <display value="Imatinib"/>
    </coding>
    <coding>
      <system value="http://fhir.de/CodeSystem/bfarm/atc"/>
      <version value="2021"/>
      <code value="L01EA01"/>
      <display value="Imatinib"/>
    </coding>
    <text value="Imatinib (BCR-ABL Tyrosinkinase-Inhibitor)"/>
  </medicationCodeableConcept>
  <subject>🔗 
    <reference value="Patient/example"/>
  </subject>
  <effectivePeriod>
    <start value="2020-12-01"/>
    <end value="2024-08-30"/>
  </effectivePeriod>
  <note>
    <text value="CML-Protokoll mit Imatinib"/>
  </note>
</MedicationStatement>